Rozerem is the first prescription insomnia medication with a novel therapeutic mechanism of action in 35 years. Rozerem is the first and only prescription sleep medication that has shown no evidence of abuse and dependence and, as a result, has not been designated as a controlled substance by the U.S. Drug Enforcement Administration (DEA). With the exception of ROZEREM, all other prescription medications indicated for insomnia are classified as Schedule IV controlled substances by the DEA.
Rozerem works by specifically binding to receptors in the brain called MT1 and MT2 (melatonin receptors). Melatonin is released in a cycle that corresponds to sleep (night). Activation of the MT1 and MT2 receptors in the brain stops an alerting signal, which is thought to facilitate the onset of sleep. It does not act like other sleep drugs, which act through benzonbiazpine receptors. The MT1/2 receptors control many physiological functions other than sleep, such as blood pressure and immune cell signaling.
Rozerem is made by Takeda Pharmaceuticals
Subscribe to:
Post Comments (Atom)
1 comment:
I just checked out this rxdrugcard.com site. They have a place to look up their drug prices before you sign up! Cool.
Post a Comment